Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CD207 |
| Upstream (Parents) |
|---|
| (<<) KRT5 → CD207 |
| (<<) TNNC2 → CD207 |
| (<<) UTS2 → CD207 |
| (<<) HES1 → CD207 |
| (<<) PRDM5 → CD207 |
| (<<) NOVA2 → CD207 |
| (<<) HTN1 → CD207 |
| (<<) INVS → CD207 |
| (<<) TSPO2 → CD207 |
| (<<) DLX4 → CD207 |
| Downstream (Children) |
|---|
| CD207 → FOXI1 (>>) |
